Stocktoria
HALOZYME THERAPEUTICS, INC. HALO
HALOZYME THERAPEUTICS, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 17,619,937 | $922.6M | 14.22% |
| D. E. Shaw & Co., Inc. | 2,044,479 | $160.0M | 1.65% |
| TWO SIGMA INVESTMENTS, LP | 1,653,285 | $129.4M | 1.33% |
| RENAISSANCE TECHNOLOGIES LLC | 598,111 | $66.0M | 0.48% |
| AQR CAPITAL MANAGEMENT LLC | 785,556 | $61.5M | 0.63% |
| Bridgewater Associates, LP | 463,146 | $36.3M | 0.37% |
| CITADEL ADVISORS LLC | 422,490 | $33.1M | 0.34% |
| SOROS FUND MANAGEMENT LLC | 64,118 | $7.1M | 0.05% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.